Patents by Inventor Alan DeAngelis
Alan DeAngelis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11374180Abstract: Compounds are provided that comprise a ligand having a 5-substituted 2-phenylquinoline. In particular, the 2-phenylquinoline may be substituted with a cycloalkyl containing group at the 5-position. These compounds may be used in organic light emitting devices, in particular as red emitters in the emissive layer of such devices, to provide devices having improved properties.Type: GrantFiled: April 29, 2020Date of Patent: June 28, 2022Assignee: UNIVERSAL DISPLAY CORPORATIONInventors: Chuanjun Xia, Bin Ma, David Zenan Li, Bert Alleyne, Alan Deangelis, James Fiordeliso, Vadim Adamovich
-
Patent number: 11296283Abstract: A compound including a ligand LA of Formula I is disclosed.Type: GrantFiled: May 29, 2019Date of Patent: April 5, 2022Assignee: UNIVERSAL DISPLAY CORPORATIONInventors: Zhiqiang Ji, Pierre-Luc T. Boudreault, Alexey Borisovich Dyatkin, Jui-Yi Tsai, Jerald Feldman, Bin Ma, Alan Deangelis
-
Publication number: 20220077408Abstract: Provided are organometallic compounds having a ligand LA of Formula I: Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.Type: ApplicationFiled: August 18, 2021Publication date: March 10, 2022Applicant: Universal Display CorporationInventors: Zhiqiang JI, Wei-Chun Shih, Alan DeAngelis, Pierre-Luc T. Boudreault
-
Publication number: 20220037598Abstract: A compound comprising a heteroleptic iridium complex having a structure of Formula II, is provided. In Formula II, each of R1, R2, R3, R4, R5, and R6, is independently selected from the group consisting of hydrogen, deuterium, cycloalkyl, deuterated cycloalkyl, alkyl, and deuterated alkyl; at least one of R1, R2, R3, R4, R5, and R6 is not hydrogen or deuterium; and each R and R? is independently selected from a variety of substitutions. OLEDs and formulations containing the compound of Formula II are also provided.Type: ApplicationFiled: October 6, 2021Publication date: February 3, 2022Applicant: Universal Display CorporationInventors: BIN MA, Alan Deangelis, Chuanjun Xia, Bert Alleyne
-
Publication number: 20220009955Abstract: A compound comprising a first bidentate ligand LA, wherein LA comprises a structure of Formula I; wherein Z is selected from the group consisting of O, S, NR, BR, CRKRL, C?CRKRL, SiRKRL, —CRKRLCRMRN—, —SiRKRLSiRMRN—, —CRKRLO—, —SiRKRLO—, and —CRK?CRL—; wherein ring A, ring B, and ring C are each independently a 5-membered carbocyclic ring, 5-membered heterocyclic ring, 6-membered carbocyclic ring or 6-membered heterocyclic ring; wherein LA is coordinated to a metal M forming a 5-membered chelate ring; wherein M is selected from the group consisting of Ir, Pt, Pd, Ru, Rh, Os, Re, Cu, Ag, and Au; wherein RA, RB, and RC each represent mono to the maximum allowable substitution, or no substitution; wherein each R, RK, RL, RM, RN, RA, RB, and RC is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, selenyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aType: ApplicationFiled: September 14, 2021Publication date: January 13, 2022Inventors: Alexey Borisovich Dyatkin, Jui-Yi Tsai, Walter Yeager, Pierre-Luc T. Boudreault, Zhiqiang Ji, Alan DeAngelis
-
Patent number: 11189805Abstract: Heteroleptic iridium complexes having the formula are disclosed. In this formula, R1, R2, R3, R4, R5, and R6, are selected from hydrogen, deuterium, cycloalkyl, deuterated cycloalkyl, alkyl, and deuterated alkyl, and can optionally be linked together to form a ring; at least one of R1, R2, R3, R4, R5, and R6 is cycloalkyl, deuterated cycloalkyl, alkyl, or deuterated alkyl; ring A is attached to the 4- or 5-position of ring B; and R and R? can represent any of a variety of subsitutents. These iridium compounds contain alkyl substituted phenylpyridine ligands, which provide these compounds with beneficial properties when the iridium complexes are incorporated into OLED devices.Type: GrantFiled: October 24, 2018Date of Patent: November 30, 2021Assignee: UNIVERSAL DISPLAY CORPORATIONInventors: Bin Ma, Alan DeAngelis, Chuanjun Xia, Bert Alleyne
-
Publication number: 20210323968Abstract: A compound containing indolocarbazole having a formula: Formula I is disclosed.Type: ApplicationFiled: June 15, 2021Publication date: October 21, 2021Applicant: UNIVERSAL DISPLAY CORPORATIONInventors: BIN MA, VADIM ADAMOVICH, ALAN DEANGELIS, TING-CHIH WANG
-
Patent number: 11117897Abstract: A compound containing indolocarbazole having a formula: Formula I is disclosed.Type: GrantFiled: March 22, 2018Date of Patent: September 14, 2021Assignee: UNIVERSAL DISPLAY CORPORATIONInventors: Bin Ma, Vadim Adamovich, Alan Deangelis, Ting-Chih Wang
-
Patent number: 11114624Abstract: The present invention includes a new series of benzofused heterocyclic ligands for metal complexes. These complexes show promising photophysical performance when incorporated into OLEDs.Type: GrantFiled: March 17, 2020Date of Patent: September 7, 2021Assignee: UNIVERSAL DISPLAY CORPORATIONInventors: Mingjuan Su, Walter Yeager, Alan Deangelis, Bin Ma, Jui-Yi Tsai, Lichang Zeng, Chuanjun Xia
-
Patent number: 11108000Abstract: A compound having the formula Ir(LA)n(LB)3?n is disclosed wherein LA is an aza-DBF ligand and LB is an alkyl-substituted phenylpyridine ligand, wherein the compound has a structure according to Formula I: wherein A1, A2, A3, A4, A5, A6, A7, and A8 comprise carbon or nitrogen; wherein at least one of A1, A2, A3, A4, A5, A6, A7, and A8 is nitrogen; wherein ring B is bonded to ring A through a C—C bond; wherein the iridium is bonded to ring A through a Ir—C bond; wherein X is O, S, or Se; wherein R1 and R2 each independently represent mono-, di-, tri-, tetra-substitution, or no substitution; wherein R? and R? each independently represent mono-, di-substitution, or no substitution; wherein any adjacent substitutions in R?, R?, R1, R2, R3, R4, R5, and R6 are optionally linked together to form a ring; wherein R1, R2, R?, and R? are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl,Type: GrantFiled: May 3, 2018Date of Patent: August 31, 2021Assignee: UNNIVERSAL DISPLAY CORPORATIONInventors: Bin Ma, Walter Yeager, Edward Barron, Alan Deangelis, Chuanjun Xia, Vadim Adamovich, Scott Beers, Harvey R. Wendt, Suman Layek
-
Patent number: 10978648Abstract: Novel heteroleptic iridium carbene complexes are provided. The complexes have lower-than expected sublimation temperatures, which is beneficial for the processing of these materials in solid state applications. Selective substitution of the ligands provides for phosphorescent compounds that are suitable for use in a variety of OLED devices. The carbene complexes can also be used as materials in a hole blocking layer and/or an electron transport layer to improve device performance.Type: GrantFiled: September 28, 2017Date of Patent: April 13, 2021Assignee: UNIVERSAL DISPLAY CORPORATIONInventors: Chun Lin, Bin Ma, Chuanjun Xia, Lichang Zeng, Alan Deangelis, Edward Barron
-
Publication number: 20210095195Abstract: A compound having a Pt tetradentate structure of Formula 1, is provided. In the structure of Formula 1, rings C and D each independently represent 5- or 6-membered carbocyclic or heterocyclic ring; L1, L2, and L3 are each independently a direct bond, BR, NR, PR, O, S, Se, C?O, S?O, SO2, SiRR?, GeRR?, alkyl, cycloalkyl, or a combination thereof; the sum of n1 and n2 is 1 or 2; X is selected from NRE, O, S, and Se; X3 and X4 each independently carbon or nitrogen; and one of Q1, Q3, and Q4 is oxygen, and the remaining two of Q1, Q3, and Q4 each represents a direct bond. Formulations and devices, such as an OLEDs, that include the compound of Formula 1 are also described.Type: ApplicationFiled: December 10, 2020Publication date: April 1, 2021Applicant: Universal Display CorporationInventors: Bin MA, Mingjuan SU, Alan DEANGELIS, Edward BARRON, Chuanjun XIA
-
Publication number: 20210083202Abstract: A compound useful as a host material in an OLED is provided. The compound includes at least one chemical group selected from the group consisting of triphenylene, carbazole, indolocarbazole, dibenzothiphene, dibenzofuran, dibenzoselenophene, aza-triphenylene, azacarbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene; wherein the compound is substituted by at least one R selected from the group consisting of alkyl, cycloalkyl, spiroalkyl, partially or fully deuterated variants thereof, partially or fully fluorinated variants thereof, and combination thereof.Type: ApplicationFiled: November 24, 2020Publication date: March 18, 2021Applicant: Universal Display CorporationInventors: BIN MA, ALAN DEANGELIS
-
Publication number: 20210074931Abstract: A compound of: is disclosed. In Formula IV, ring B and ring C are each independently a 5 or 6-membered carbocyclic or heterocyclic ring; A-B represents a bonded pair of carbocyclic or heterocyclic rings coordinated to a metal M via a nitrogen atom in ring A and an sp2 hybridized atom in ring B; A-C represents a bonded pair of carbocyclic or heterocyclic rings; M is a metal having an atomic number greater than 40; L? is a monoanionic bidentate ligand; m is the oxidation state of the metal M; and n is at least 1.Type: ApplicationFiled: November 19, 2020Publication date: March 11, 2021Applicant: Universal Display CorporationInventors: Chuanjun XIA, Bert ALLEYNE, Raymond C. KWONG, James FIORDELISO, Michael S. WEAVER, Nasrin ANSARI, Alan DEANGELIS, Dinesh RAYABARAPU, Vadim ADAMOVICH
-
Patent number: 10897016Abstract: A compound useful as a host material in an OLED is provided. The compound includes at least one chemical group selected from the group consisting of triphenylene, carbazole, indolocarbazole, dibenzothiphene, dibenzofuran, dibenzoselenophene, aza-triphenylene, azacarbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene; wherein the compound is substituted by at least one R selected from the group consisting of alkyl, cycloalkyl, spiroalkyl, partially or fully deuterated variants thereof, partially or fully fluorinated variants thereof, and combination thereof.Type: GrantFiled: October 20, 2017Date of Patent: January 19, 2021Assignee: UNIVERSAL DISPLAY CORPORATIONInventors: Bin Ma, Alan Deangelis
-
Patent number: 10892426Abstract: An OLED containing an emissive dopant that is a heteroleptic complex having the formula Ir(LA-B)2(LC-D) is disclosed.Type: GrantFiled: January 14, 2020Date of Patent: January 12, 2021Assignee: UNIVERSAL DISPLAY CORPORATIONInventors: Chuanjun Xia, Bert Alleyne, Raymond C. Kwong, James Fiordeliso, Michael S. Weaver, Nasrin Ansari, Alan Deangelis, Dinesh Rayabarapu, Vadim Adamovich
-
Patent number: 10889754Abstract: A compound having a Pt tetradentate structure of Formula 1, is provided. In the structure of Formula 1, rings C and D each independently represent 5- or 6-membered carbocyclic or heterocyclic ring; L1, L2, and L3 are each independently a direct bond, BR, NR, PR, O, S, Se, C?O, S?O, SO2, SiRR?, GeRR?, alkyl, cycloalkyl, or a combination thereof; the sum of n1 and n2 is 1 or 2; X is selected from NRE, O, S, and Se; X3 and X4 each independently carbon or nitrogen; and one of Q1, Q3, and Q4 is oxygen, and the remaining two of Q1, Q3, and Q4 each represents a direct bond. Formulations and devices, such as an OLEDs, that include the compound of Formula 1 are also described.Type: GrantFiled: October 18, 2018Date of Patent: January 12, 2021Assignee: UNIVERSAL DISPLAY CORPORATIONInventors: Bin Ma, Mingjuan Su, Alan Deangelis, Edward Barron, Chuanjun Xia
-
Publication number: 20210002311Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.Type: ApplicationFiled: June 12, 2020Publication date: January 7, 2021Applicant: Universal Display CorporationInventors: Zhiqiang JI, Pierre-Luc T. BOUDREAULT, Wei-Chun SHIH, Alan DEANGELIS
-
Patent number: 10840458Abstract: Novel organic materials containing indolocarbazoles as donor connected with electron acceptors such as quinoxaline or dibenzoquinoxaline for PHOLED devices are disclosed.Type: GrantFiled: May 15, 2017Date of Patent: November 17, 2020Assignee: UNIVERSAL DISPLAY CORPORATIONInventors: Bin Ma, Alan Deangelis, Lichang Zeng, Chuanjun Xia, Jerald Feldman
-
Publication number: 20200308204Abstract: A compound comprising a first bidentate ligand LA, wherein LA comprises a structure of Formula I; wherein Z is selected from the group consisting of O, S, NR, BR, CRKRL, SiRKRL, —CRKRLCRMRN—, —SiRKRLSiRMRN—, —CRKRLO—, —SiRKRLO—, and —CRK?CRL—; wherein ring A, ring B, and ring C are each independently a 5-membered carbocyclic ring, 5-membered heterocyclic ring, 6-membered carbocyclic ring or 6-membered heterocyclic ring; wherein LA is coordinated to a metal M forming a 5-membered chelate ring; wherein M is selected from the group consisting of Ir, Pt, Pd, Ru, Rh, Os, Re, Cu, Ag, and Au; wherein RA, RB, and RC each represent mono to the maximum allowable substitution, or no substitution; wherein each R, RK, RL, RM, RN, RA, RB, and RC is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carType: ApplicationFiled: March 26, 2020Publication date: October 1, 2020Inventors: Alexey Borisovich DYATKIN, Jui-Yi TSAI, Walter YEAGER, Pierre-Luc T. BOUDREAULT, Zhiqiang JI, Alan DeAngelis